Related Experiment Videos
Specificity of resistance to oxidative stress
Richard Dargusch1, David Schubert
1Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA.
Abstract:
Two clonal nerve-like cell lines derived from HT22 and PC12 have been selected for resistance to glutamate toxicity and amyloid toxicity, respectively. In the following experiments it was asked if these cell lines show cross-resistance toward amyloid beta peptide (Abeta) and glutamate as well as toward a variety of additional neurotoxins. Conversely, it was determined if inhibitors of oxytosis, a well-defined oxidative stress pathway, also protect cells from the neurotoxins. It is shown that both glutamate and amyloid resistant cells are cross resistant to most of the other toxins or toxic conditions, while inhibitors of oxytosis protect from glutathione and cystine depletion and H2O2 toxicity, but not from the toxic effects of nitric oxide, rotenone, arsenite or cisplatin. It is concluded that while there is a great deal of cross-resistance to neurotoxins, the components of the cell death pathway which has been defined for oxytosis are not used by many of the neurotoxins.
Insights
Neurotoxic insults like glutamate and amyloid beta peptide induce cross-resistance in nerve cells. However, inhibitors of oxytosis, an oxidative stress pathway, only protect against specific toxins, not all neurotoxins.
Area of Science:
- Neuroscience
- Cell Biology
- Toxicology
Background:
- Glutamate and amyloid beta peptide are implicated in neurodegenerative diseases.
- Oxidative stress pathways, such as oxytosis, play a role in neuronal cell death.
- Understanding neurotoxin resistance mechanisms is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate cross-resistance to various neurotoxins in cell lines resistant to glutamate or amyloid beta.
- To determine if inhibitors of oxytosis protect against these neurotoxins.
- To elucidate the involvement of oxytosis pathway components in neurotoxin-induced cell death.
Main Methods:
- Selection of HT22 and PC12 cell lines for resistance to glutamate and amyloid toxicity.
- Exposure of resistant cell lines to amyloid beta peptide, glutamate, and other neurotoxins.
- Treatment with inhibitors of the oxytosis pathway.
- Assessment of cell viability and protection against toxic insults.
Main Results:
- Glutamate and amyloid-resistant cells exhibited cross-resistance to most tested neurotoxins.
- Oxytosis inhibitors protected cells from glutathione/cystine depletion and H2O2 toxicity.
- Oxytosis inhibitors did not protect against nitric oxide, rotenone, arsenite, or cisplatin toxicity.
Conclusions:
- Significant cross-resistance to neurotoxins exists in selected nerve-like cell lines.
- The oxytosis pathway is not universally involved in the cell death mechanisms of all tested neurotoxins.
- These findings suggest distinct cellular defense mechanisms against different types of neurotoxicity.